Reasons for delays in treatment of patients suffering from malignant cancers in Podkarpackie voivodeship

Authors

  • Justyna Podgórska Chair of Rehabilitation, Faculty of Medicine, University of Rzeszów, Poland Author
  • Wacław Kruk Chair of Public Health, Faculty of Medicine, University of Rzeszów, Poland Author
  • Izabela Cichocka Chair of Quantitative Methods In Economics, Faculty of Economics, University of Information Technology and Management in Rzeszów, Poland Author

DOI:

https://doi.org/10.12923/j.0044-2011/123-2/a.03

Keywords:

cancer , oncological prophylaxis , treatment delays

Abstract

Introduction.  In  the  case  of  oncological  patients,  early implementation of treatment is a  key matter. Any delays oc- curring on each of the levels of diagnostic and therapeutic processes  may affect the outliving of the patients. Elimina- tion of their reasons could reduce the time  scale of the de- lays,  increase  the  percentage  of  cancer  instances  detected in initial stages, as well as improve patients’ prognoses.

Aim. The basic objective of this thesis was to identify the main reasons for the delays in the  treatment of oncological patients.  The  additional  goal  was  to  establish  the  sources of information on prophylaxis collected by the patients.

Material and methods. The research comprised108 peo- ple who were treated in a stationary treatment system in two specialized  oncology  centers  in  Podkarpacie.  The  method consisted in a diagnostic poll and the employed technique was a survey carried out in the form of a standardized  inter- view.

Results. Among the reasons for the delays that patients contributed  to  the  most  commonly  mentioned  were:  lack of knowledge about the symptoms that could suggest cancer and as well as disregarding the symptoms. Eighty-one per cent of the respondents gave more than one reason. Among all respondents, 84% do not know the symptoms that may suggest cancer, 98% claim that actions, which promote this area of knowledge, are needed, and the highest rated source of information is a GP.

Conclusions. The majority of the reasons for the delays in cancer treatment are those, which lie on the side of pa- tients and these are also responsible for the longest average time of procrastination. Delays in treatment on account of the health care system organization seem to be a relatively smaller problem in comparison to those on the side of pa- tients.  General  practitioner,  who  constitutes  an  essential link in the system of fight against cancer in the population, is considered by the patients to be the most reliable source of information on oncological prophylaxis.

References

1. Jędrzejczak W, Deptała A. Czym jest nowotwór, czyli wstęp do biologii nowotworów. In: A. Deptała (ed). Onkologia w praktyce. Warszawa: PZWL; 2006. p.14.

2. Kulik TB, Stefanowicz A, Pacian A, Żołnierczuk-Kieliszek D. Możliwość profilaktyki chorób nowotworowych w podstawowej opiece zdrowotnej. Zdr Publ. 2004;114(3):275-8.

3. Robinson KM, Ottesen B, Christensen KB, Allan Krasnik A. Diagnostic delay experienced among gynecological cancer patients: A nationwide survey in Denmark. Acta Obstet Gynecol Scand. 2009;88:685-92. Review match

4. Korzeniowska E, Puchalski K. Promocja zdrowia w miejscu pracy w Polsce. Materiały z konferencji. Promocja zdrowia w polityce zdrowotnej i społecznej państwa. Warszawa; 2005. Review match

5. Pawlicki M, Michalczyk A. Badania przyczyn opóźnień leczenia chorych na nowotwory złośliwe. Współ Onkol. 2005;9(5):191-5.

6. Wronkowski Z, Brużewicz S. Chemioterapia i radioterapia. Warszawa: PZWL; 2007. p. 5.

7. Pawlicki M, Rysz B. Badania nad przyczynami opóźnień w rozpoczęciu leczenia na nowotwory złośliwe. Nowotwory. 2001;519(5):494-8.

8. Pawlicki M, Rachtan J, Brandys A, et al. Przyczyny opóźnień leczenia chorych na nowotwory złośliwe. Post N Med. 1992;5:35-6.

9. Pawlicki M, Rachtan J, Żuchowska B. Ocena przyczyn opóźnionego leczenia chorych na nowotwory złośliwe. Nowotwory. 1989;39(1):31-6.

10. Facione NC, Miaskowski C, Dodd MJ, Paul SM. The self-reported likelihood of patient delay in breast cancer: new thoughts for early detection. Prev Med. 2002;34(4):397-407. Review match

11. Boffetta P, Parkin DM. Cancer in developing countries. CA Cancer J Clin. 1994;44(2):81-90.

12. Malik IA, Gopalan S. Use of CAM results in delay in seeking medical advice for breast cancer. Eur J Epidemiol. 2003;18(8):817-22. Review match

13. Mandelblatt J, Andrews H, Kerner J, et al. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health.1991;81(5):646-9. Review match

14. Wright GP, Wong J, Morgan JW, et al. Time from Diagnosis to Surgical Treatment of Breast Cancer: Factors Influencing Delays in Initiating Treatment. Am Surg. 2010;76(10):1119-22. Review match

15. Kaplan CP, Crane LA, Stewart S, Juarez-Reyes M. Factors affecting follow-up among low-income women with breast abnormalities. J Womens Health (Larchmt). 2004;13:195-206. Review match

16. O’Brien MA, Whelan TJ, Villasis-Keever M, et al. Are cancer-related decision aids effective? A systematic review and meta-analysis. J Clin Oncol. 2009;27:974-85. Review match

Downloads

Published

2013-04-01